Walleye Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-55,761
| Closed | -$334K | – | 1688 |
|
|
2023
Q4 | $334K | Buy |
55,761
+45,805
| +460% | +$274K | ﹤0.01% | 959 |
|
|
2023
Q3 | $70.5K | Buy |
9,956
+9,466
| +1,932% | +$67K | ﹤0.01% | 1170 |
|
|
2023
Q2 | $3.45K | Buy |
+490
| New | +$3.45K | ﹤0.01% | 1219 |
|
|
2023
Q1 | – | Sell |
-62,105
| Closed | -$713K | – | 1632 |
|
|
2022
Q4 | $713K | Buy |
62,105
+46,016
| +286% | +$528K | ﹤0.01% | 573 |
|
|
2022
Q3 | $203K | Buy |
16,089
+4,669
| +41% | +$58.9K | ﹤0.01% | 1111 |
|
|
2022
Q2 | $121K | Sell |
11,420
-7,912
| -41% | -$83.8K | ﹤0.01% | 1285 |
|
|
2022
Q1 | $314K | Sell |
19,332
-17,390
| -47% | -$282K | ﹤0.01% | 976 |
|
|
2021
Q4 | $509K | Sell |
36,722
-87,981
| -71% | -$1.22M | ﹤0.01% | 778 |
|
|
2021
Q3 | $1.79M | Buy |
124,703
+21,006
| +20% | +$302K | 0.01% | 323 |
|
|
2021
Q2 | $1.64M | Buy |
+103,697
| New | +$1.64M | 0.01% | 301 |
|
|
2021
Q1 | – | Sell |
-18,772
| Closed | -$140K | – | 1613 |
|
|
2020
Q4 | $140K | Buy |
+18,772
| New | +$140K | ﹤0.01% | 1026 |
|
|
2020
Q2 | – | Sell |
-42,086
| Closed | -$84K | – | 1170 |
|
|
2020
Q1 | $84K | Sell |
42,086
-3,000
| -7% | -$5.99K | ﹤0.01% | 818 |
|
|
2019
Q4 | $156K | Buy |
+45,086
| New | +$156K | ﹤0.01% | 930 |
|
|
2018
Q4 | – | Sell |
-1,245
| Closed | -$9K | – | 1451 |
|
|
2018
Q3 | $9K | Buy |
+1,245
| New | +$9K | ﹤0.01% | 1631 |
|
|
2017
Q2 | – | Sell |
-37,700
| Closed | -$317 | – | 1397 |
|
|
2017
Q1 | $317 | Buy |
+37,700
| New | +$317 | ﹤0.01% | 696 |
|
|
2016
Q1 | – | Sell |
-2,000
| Closed | -$21K | – | 1808 |
|
|
2015
Q4 | $21K | Sell |
2,000
-1,600
| -44% | -$16.8K | ﹤0.01% | 1467 |
|
|
2015
Q3 | $41K | Buy |
3,600
+3,100
| +620% | +$35.3K | ﹤0.01% | 1038 |
|
|
2015
Q2 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 1357 |
|